Gavin Corcoran is Chief R&D Officer of Sio Gene Therapies Inc.. Currently has a direct ownership of 25,792 shares of SIOX, which is worth approximately $0. The most recent transaction as insider was on Mar 17, 2021, when has been sold 16,001 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K
0% 3M change
0% 12M change
Total Value Held $0

Gavin Corcoran Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2021
BUY
Grant, award, or other acquisition
-
16,001 Added 38.29%
25,792 Common Stock
GC

Gavin Corcoran

Chief R&D Officer
New York, NY

Track Institutional and Insider Activities on SIOX

Follow Sio Gene Therapies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SIOX shares.

Notify only if

Insider Trading

Get notified when an Sio Gene Therapies Inc. insider buys or sells SIOX shares.

Notify only if

News

Receive news related to Sio Gene Therapies Inc.

Track Activities on SIOX